MB Therapeutics is a pharmaceutical firm that provides patient-centric solutions for developing and producing tailored medicines.
MB Therapeutics has raised $2.1M in total funding. The most recent round was Seed. The last funding was announced in February 2025.
MB Therapeutics's investors include Bpifrance, Angels Santé, Calyseed, BEPREP, Sebastien Gallice.
MB Therapeutics is headquartered in Montpellier, France.
MB Therapeutics is a pharmaceutical firm that provides patient-centric solutions for developing and producing tailored medicines.
MB Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MB Therapeutics — Funding & Investors." VCBacked, February 24, 2025, https://www.vcbacked.co/company/mb-therapeutics. Accessed October 30, 2026.
VCBacked. (2025). MB Therapeutics — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/mb-therapeutics
{{cite web |title=MB Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mb-therapeutics |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated